Michael Brüning

Company: Bayer AG

Job title: Scientific lab head

Seminars:

Benchmarking the Role of Lipid Nanoparticles in Enhancing the Effectiveness of mRNA-Based Therapeutics 1:00 pm

Recent advances in medicine have led to the development of mRNA-based therapeutics, which have shown promise in treating various diseases. However, the effectiveness of these therapeutics is limited by their inability to penetrate cell membranes. By using lipid nanoparticles, the effectiveness of mRNA-based therapeutics can be greatly enhanced. In fact, several studies have shown that…Read more

day: Pre-Conference Workshop Day